Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Kidney Stone Risk
THURSDAY, Feb. 8, 2024 (HealthDay News) -- For adults with type 2 diabetes, initiation of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may lower the risk for nephrolithiasis, accordi...